Walgreens Boots Alliance has sold more shares of drug distributor Cencora for proceeds of about $300 million, “primarily for debt paydown and general corporate purposes,” the company said ...

--(BUSINESS WIRE)--Cencora, Inc. (NYSE ... value chain to facilitate and optimize market access to therapies. Care providers depend on us for the secure, reliable delivery of pharmaceuticals ...

Walgreens is offloading more shares in drug distributor Cencora as the struggling pharmacy chain looks to generate cash. The latest sale netted about $300 million for Walgreens, and shrinks the ...

Cencora is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We partner with pharmaceutical innovators across the value ...

Through the sure supply program, providers can help lessen the impacts of shortages for at-risk treatments so they can focus on what matters most?taking care of their patients." Cencora leverages ...

Our leadership supporting specialty providers is a key differentiator and growth driver for Cencora and we've evolved our service offerings over time. Over decades, we've deepened our ...

Cencora (COR) has significantly expanded the number and type of medications available in its sure supply program, a drug shortage mitigation initiative designed to provide health systems with ...